Streetbeat News

Stock Prices

OPHC

OptimumBank Holdings (NASDAQ: OPHC) reported Q3 2024 earnings per share (EPS) of $0.34, significantly surpassing the analyst consensus estimate of $0.16 by 112.5%.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 2:07 pm

MQ

Over the past three months, six analysts have provided diverse evaluations of Marqeta (NASDAQ:MQ), ranging from bullish to bearish. The average 12-month price target has decreased by 11.28% to $6.92. Analysts have adjusted their ratings and price targets in response to Marqeta's recent performance, which includes a significant revenue decline and below-industry-average financial metrics.

Portfolio Pulse from Benzinga Insights

August 06, 2024 | 2:01 pm

COIN

Analysts have provided a range of opinions on Coinbase Glb (NASDAQ:COIN) over the past quarter, with a mix of bullish, somewhat bullish, indifferent, and somewhat bearish ratings. The average 12-month price target has increased to $265.0. Key analysts have adjusted their ratings and price targets, reflecting their views on the company's market performance and financial health.

Portfolio Pulse from Benzinga Insights

August 06, 2024 | 2:01 pm

CC

Analysts' ratings for Chemours (NYSE:CC) over the last quarter vary from bullish to bearish. The average 12-month price target has decreased by 13.71% to $26.75. Key analysts have adjusted their ratings and price targets, reflecting changing market conditions and company performance. Chemours faces challenges with a -6.39% revenue decline but shows strong profitability with a net margin of 4.55% and an ROE of 9.49%. However, its debt-to-equity ratio of 5.86 indicates increased financial risk.

Portfolio Pulse from Benzinga Insights

August 06, 2024 | 2:00 pm

VYX

NCR Voyix Corporation (NYSE:VYX) shares are trading higher following a deal with Veritas Capital to sell its cloud-based digital banking business for $2.45 billion in cash, with potential additional consideration of up to $100 million. The transaction is part of NCR Voyix's strategy to streamline operations and focus on core software and services for restaurants and retailers. The company plans to use the proceeds to reduce debt and invest in its core business areas. Despite the positive news, NCR Voyix reported disappointing Q2 earnings and reduced its FY24 revenue guidance.

Portfolio Pulse from Nabaparna Bhattacharya

August 06, 2024 | 2:00 pm

TMO

Thermo Fisher Scientific (NYSE:TMO) has significantly outperformed the market over the past 15 years, delivering an average annual return of 18.78%. A $1000 investment in TMO 15 years ago would now be worth $13,586.15. The article highlights the power of compounded returns.

Portfolio Pulse from Benzinga Insights

August 06, 2024 | 2:00 pm

FN

Fabrinet (NYSE:FN) has significantly outperformed the market over the past 10 years, delivering an average annual return of 26.09%. A $100 investment in FN stock 10 years ago would be worth $1,003.45 today. The company's current market capitalization is $7.10 billion.

Portfolio Pulse from Benzinga Insights

August 06, 2024 | 2:00 pm

BAX

Baxter International Inc (NYSE:BAX) reported strong Q2 results, beating both EPS and sales expectations. The company raised its annual outlook, driven by growth across all segments, particularly in Pharmaceuticals and Medical Products & Therapies. Baxter also provided updated guidance for 2024 and Q3, expecting continued growth. The stock rose 6.47% following the announcement.

Portfolio Pulse from Vandana Singh

August 06, 2024 | 1:59 pm

NVDA

SMCI

Super Micro Computer Inc (NASDAQ:SMCI) is set to report its Q4 earnings with Wall Street expecting $8.10 EPS and $5.29 billion in revenues. Despite a strong yearly performance driven by AI momentum, the stock is currently exhibiting bearish trends, trading below key moving averages. However, buying pressure and an oversold RSI suggest a potential bullish reversal. Analysts maintain a Buy rating with a price target of $999.92, indicating over 10% upside.

Portfolio Pulse from Surbhi Jain

August 06, 2024 | 1:52 pm

PLTR

Dan Ives from Wedbush has raised the price target for Palantir Technologies Inc. (NYSE:PLTR) from $35 to $38, with a bullish case of $50, following a transformative quarter driven by the success of its Artificial Intelligence Platform (AIP) and the launch of a new software platform, 'Warp Speed.' Palantir reported an 83% YoY increase in U.S. commercial customers.

Portfolio Pulse from Benzinga Neuro

August 06, 2024 | 1:51 pm